US Stock MarketDetailed Quotes

SONN Sonnet BioTherapeutic

Watchlist
  • 1.5498
  • +0.0898+6.15%
Trading Jan 2 10:44 ET
4.66MMarket Cap-0.14P/E (TTM)

Sonnet BioTherapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Total revenue
-87.40%18.63K
0
0
0
-50.00%18.63K
-57.76%147.81K
-40.63%37.26K
-40.63%36.85K
-61.77%36.45K
-71.30%37.26K
Operating revenue
-87.40%18.63K
--0
--0
--0
-50.00%18.63K
-57.76%147.81K
-40.63%37.26K
-40.63%36.85K
-61.77%36.45K
-71.30%37.26K
Cost of revenue
Gross profit
Operating expense
-37.34%11.87M
-12.76%3.17M
-10.72%3.53M
-32.14%3.87M
-77.03%1.3M
-36.91%18.94M
-51.11%3.64M
-50.16%3.95M
-31.36%5.7M
-10.96%5.65M
Selling and administrative expenses
-13.96%6.13M
10.01%1.97M
16.79%1.8M
-9.73%1.7M
-65.67%653.46K
-16.90%7.13M
-22.50%1.79M
-32.35%1.54M
-0.83%1.88M
-8.43%1.9M
-General and administrative expense
-13.96%6.13M
10.01%1.97M
16.79%1.8M
-9.73%1.7M
-65.67%653.46K
-16.90%7.13M
-22.50%1.79M
-32.35%1.54M
-0.83%1.88M
-8.43%1.9M
Research and development costs
-51.44%5.74M
-34.94%1.2M
-28.32%1.73M
-43.21%2.17M
-82.81%644.04K
-44.90%11.81M
-64.04%1.84M
-57.35%2.41M
-40.41%3.82M
-12.19%3.75M
Operating profit
36.95%-11.85M
11.85%-3.17M
9.88%-3.53M
31.71%-3.87M
77.21%-1.28M
36.66%-18.79M
51.20%-3.6M
50.23%-3.92M
31.00%-5.66M
9.70%-5.61M
Net non-operating interest income expense
Other net income (expense)
11,109.40%4.41M
158.47%44.78K
173.52%23.11K
183,946.55%4.23M
57.09%110.36K
23.64%-40.08K
-31.21%-76.59K
-220.93%-31.43K
-234.13%-2.3K
402.84%70.25K
Gain on sale of security
310.33%84.29K
158.47%44.78K
173.52%23.11K
-3,979.90%-93.96K
57.09%110.36K
23.64%-40.08K
-31.21%-76.59K
-220.93%-31.43K
-234.13%-2.3K
402.84%70.25K
Other non- operating income (expenses)
--4.33M
--0
----
--4.33M
----
----
----
----
----
----
Income before tax
60.51%-7.44M
14.91%-3.13M
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
Income tax
Net income
60.51%-7.44M
14.91%-3.13M
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
Net income continuous Operations
60.51%-7.44M
14.91%-3.13M
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
Minority interest income
Net income attributable to the parent company
60.51%-7.44M
14.91%-3.13M
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
60.51%-7.44M
14.91%-3.13M
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
Basic earnings per share
92.18%-11.35
78.16%-3.67
76.27%-5.6
101.06%0.64
98.24%-2.48
87.95%-145.13
94.29%-16.8039
92.63%-23.6
82.03%-60.4
44.38%-140.96
Diluted earnings per share
92.18%-11.35
78.16%-3.67
76.27%-5.6
100.93%0.56
98.24%-2.48
87.95%-145.13
94.29%-16.8039
92.63%-23.6
82.03%-60.4
44.38%-140.96
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Total revenue -87.40%18.63K000-50.00%18.63K-57.76%147.81K-40.63%37.26K-40.63%36.85K-61.77%36.45K-71.30%37.26K
Operating revenue -87.40%18.63K--0--0--0-50.00%18.63K-57.76%147.81K-40.63%37.26K-40.63%36.85K-61.77%36.45K-71.30%37.26K
Cost of revenue
Gross profit
Operating expense -37.34%11.87M-12.76%3.17M-10.72%3.53M-32.14%3.87M-77.03%1.3M-36.91%18.94M-51.11%3.64M-50.16%3.95M-31.36%5.7M-10.96%5.65M
Selling and administrative expenses -13.96%6.13M10.01%1.97M16.79%1.8M-9.73%1.7M-65.67%653.46K-16.90%7.13M-22.50%1.79M-32.35%1.54M-0.83%1.88M-8.43%1.9M
-General and administrative expense -13.96%6.13M10.01%1.97M16.79%1.8M-9.73%1.7M-65.67%653.46K-16.90%7.13M-22.50%1.79M-32.35%1.54M-0.83%1.88M-8.43%1.9M
Research and development costs -51.44%5.74M-34.94%1.2M-28.32%1.73M-43.21%2.17M-82.81%644.04K-44.90%11.81M-64.04%1.84M-57.35%2.41M-40.41%3.82M-12.19%3.75M
Operating profit 36.95%-11.85M11.85%-3.17M9.88%-3.53M31.71%-3.87M77.21%-1.28M36.66%-18.79M51.20%-3.6M50.23%-3.92M31.00%-5.66M9.70%-5.61M
Net non-operating interest income expense
Other net income (expense) 11,109.40%4.41M158.47%44.78K173.52%23.11K183,946.55%4.23M57.09%110.36K23.64%-40.08K-31.21%-76.59K-220.93%-31.43K-234.13%-2.3K402.84%70.25K
Gain on sale of security 310.33%84.29K158.47%44.78K173.52%23.11K-3,979.90%-93.96K57.09%110.36K23.64%-40.08K-31.21%-76.59K-220.93%-31.43K-234.13%-2.3K402.84%70.25K
Other non- operating income (expenses) --4.33M--0------4.33M------------------------
Income before tax 60.51%-7.44M14.91%-3.13M11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M
Income tax
Net income 60.51%-7.44M14.91%-3.13M11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M
Net income continuous Operations 60.51%-7.44M14.91%-3.13M11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M
Minority interest income
Net income attributable to the parent company 60.51%-7.44M14.91%-3.13M11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 60.51%-7.44M14.91%-3.13M11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M
Basic earnings per share 92.18%-11.3578.16%-3.6776.27%-5.6101.06%0.6498.24%-2.4887.95%-145.1394.29%-16.803992.63%-23.682.03%-60.444.38%-140.96
Diluted earnings per share 92.18%-11.3578.16%-3.6776.27%-5.6100.93%0.5698.24%-2.4887.95%-145.1394.29%-16.803992.63%-23.682.03%-60.444.38%-140.96
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Heat List
US
Overall
Symbol
Price
% Chg

No Data